Cargando…

13-year Follow-up of Treatment of Osteochondral Lesions with MACI

CATEGORY: Ankle, Arthroscopy, Hindfoot, Sports, Trauma INTRODUCTION/PURPOSE: Surgical management of osteochondral lesions of the talus (OLT) present an ongoing treatment challenge. Previously, matrix-induced autologous chondrocyte implantation (MACI) demonstrated improved pain and function at 7-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreulen, Chris, Shelton, Trevor, Nguyen, Jacqueline, Giza, Eric, Sullivan, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696745/
http://dx.doi.org/10.1177/2473011419S00044
_version_ 1784619884748996608
author Kreulen, Chris
Shelton, Trevor
Nguyen, Jacqueline
Giza, Eric
Sullivan, Martin
author_facet Kreulen, Chris
Shelton, Trevor
Nguyen, Jacqueline
Giza, Eric
Sullivan, Martin
author_sort Kreulen, Chris
collection PubMed
description CATEGORY: Ankle, Arthroscopy, Hindfoot, Sports, Trauma INTRODUCTION/PURPOSE: Surgical management of osteochondral lesions of the talus (OLT) present an ongoing treatment challenge. Previously, matrix-induced autologous chondrocyte implantation (MACI) demonstrated improved pain and function at 7-years postoperative, providing evidence that MACI is a reliable method for treating cartilage. However, it is unknown the long- term results of MACI in OLT. The purpose of this study was to assess 13-year clinical follow-up data and the long-term success of this implant by comparing patient reported outcome measures (PROMs) pre-operatively, at 7-years post-operative, and at 13- years post-operative. METHODS: A prospective investigation of MACI was performed on 10 patients with OLTs who had failed previous arthroscopic treatment. Of the 10 patients, 9 were available for 7-year and 13-year follow-up. Short Form Health Survey (SF-36) and the American Orthopaedic Foot & Ankle Society (AOFAS) hindfoot evaluation were utilized at pre-operative, 7-year, a 13-year postoperative. For each patient, a paired t-test was used to compare 13-year post-operative PROMs to pre-operative PROMs. A single factor analysis of variance (ANOVA) determined whether PROMs were different between pre-operative, 7-year post- operative, and 13-year post-operative time intervals. When a significant difference was detected, a post-hoc Tukey’s determined which time periods were different. RESULTS: SF-36 data at 13-years showed significant improvements in Physical Functioning (p=0.012), Lack of Bodily Pain (p=0.017), and Social Functioning (p=0.007) compared with preoperative data. There were no differences in other components of the SF-36 outcomes (p>0.05). Although the AOFAS was on average 12 points higher at 13-years postoperative, this was not statistically significant (p=0.173). As for comparing PROMs over time, 13-years post-operative PROMs were comparable to 7-years post- operative (Table 1). There were better PROMs for Physical Functioning, Bodily Pain, and Social Functioning at 7- and 13-years post-operative compared to pre-operative while Physical Role Functioning was also better at 7-years post-operative compared to pre-operative. CONCLUSION: This study shows MACI provides greater pain relief and function at 13-years post-operative with stable long-term follow-up. MACI should be considered for osteochondral lesions that fail initial microfracture.
format Online
Article
Text
id pubmed-8696745
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86967452022-01-28 13-year Follow-up of Treatment of Osteochondral Lesions with MACI Kreulen, Chris Shelton, Trevor Nguyen, Jacqueline Giza, Eric Sullivan, Martin Foot Ankle Orthop Article CATEGORY: Ankle, Arthroscopy, Hindfoot, Sports, Trauma INTRODUCTION/PURPOSE: Surgical management of osteochondral lesions of the talus (OLT) present an ongoing treatment challenge. Previously, matrix-induced autologous chondrocyte implantation (MACI) demonstrated improved pain and function at 7-years postoperative, providing evidence that MACI is a reliable method for treating cartilage. However, it is unknown the long- term results of MACI in OLT. The purpose of this study was to assess 13-year clinical follow-up data and the long-term success of this implant by comparing patient reported outcome measures (PROMs) pre-operatively, at 7-years post-operative, and at 13- years post-operative. METHODS: A prospective investigation of MACI was performed on 10 patients with OLTs who had failed previous arthroscopic treatment. Of the 10 patients, 9 were available for 7-year and 13-year follow-up. Short Form Health Survey (SF-36) and the American Orthopaedic Foot & Ankle Society (AOFAS) hindfoot evaluation were utilized at pre-operative, 7-year, a 13-year postoperative. For each patient, a paired t-test was used to compare 13-year post-operative PROMs to pre-operative PROMs. A single factor analysis of variance (ANOVA) determined whether PROMs were different between pre-operative, 7-year post- operative, and 13-year post-operative time intervals. When a significant difference was detected, a post-hoc Tukey’s determined which time periods were different. RESULTS: SF-36 data at 13-years showed significant improvements in Physical Functioning (p=0.012), Lack of Bodily Pain (p=0.017), and Social Functioning (p=0.007) compared with preoperative data. There were no differences in other components of the SF-36 outcomes (p>0.05). Although the AOFAS was on average 12 points higher at 13-years postoperative, this was not statistically significant (p=0.173). As for comparing PROMs over time, 13-years post-operative PROMs were comparable to 7-years post- operative (Table 1). There were better PROMs for Physical Functioning, Bodily Pain, and Social Functioning at 7- and 13-years post-operative compared to pre-operative while Physical Role Functioning was also better at 7-years post-operative compared to pre-operative. CONCLUSION: This study shows MACI provides greater pain relief and function at 13-years post-operative with stable long-term follow-up. MACI should be considered for osteochondral lesions that fail initial microfracture. SAGE Publications 2019-10-28 /pmc/articles/PMC8696745/ http://dx.doi.org/10.1177/2473011419S00044 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Kreulen, Chris
Shelton, Trevor
Nguyen, Jacqueline
Giza, Eric
Sullivan, Martin
13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title 13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title_full 13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title_fullStr 13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title_full_unstemmed 13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title_short 13-year Follow-up of Treatment of Osteochondral Lesions with MACI
title_sort 13-year follow-up of treatment of osteochondral lesions with maci
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696745/
http://dx.doi.org/10.1177/2473011419S00044
work_keys_str_mv AT kreulenchris 13yearfollowupoftreatmentofosteochondrallesionswithmaci
AT sheltontrevor 13yearfollowupoftreatmentofosteochondrallesionswithmaci
AT nguyenjacqueline 13yearfollowupoftreatmentofosteochondrallesionswithmaci
AT gizaeric 13yearfollowupoftreatmentofosteochondrallesionswithmaci
AT sullivanmartin 13yearfollowupoftreatmentofosteochondrallesionswithmaci